Trial Profile
Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Jul 2019
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Bone metastases
- Focus Therapeutic Use
- 19 Jul 2017 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
- 19 Jul 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.
- 09 Dec 2015 New trial record